Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.33 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16357470 | 0.96 | MAPT (0.36) | MAPTCYP11B2CYP11B1CYP19A1CYP17A1 | |
| SCHEMBL20426187 | 0.87 | CYP11B2 (0.38) | MAPTCYP11B2CYP11B1CYP19A1L3MBTL1 | |
| SCHEMBL20426249 | 0.87 | CYP3A4 (0.36) | MAPTCYP11B2L3MBTL1KDM4EATM | |
| SCHEMBL20426140 | 0.86 | MAPT (0.41) | MAPTCYP11B2CYP11B1CYP19A1CYP17A1 | |
| SCHEMBL20426230 | 0.86 | COMT (0.37) | MAPTCYP11B2CYP11B1CYP19A1CYP17A1 | |
| SCHEMBL20426237 | 0.85 | CYP2A6 (0.39) | MAPTCYP19A1ALDH1A1G6PD | |
| SCHEMBL15802038 | 0.85 | L3MBTL1 (0.40) | MAPTL3MBTL1KDM4EATMALDH1A1 | |
| SCHEMBL16357541 | 0.84 | COMT (0.37) | MAPTCYP11B2CYP11B1CYP19A1CYP17A1 | |
| SCHEMBL16357509 | 0.84 | G6PD (0.38) | MAPTCYP11B2CYP11B1CYP19A1CYP17A1 | |
| SCHEMBL16357543 | 0.83 | CYP19A1 (0.39) | MAPTCYP11B2CYP11B1CYP19A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | IDO1, IDO2, KYNU | MAPT 459/4885CYP11B2 888/4885CYP11B1 949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.